US biotech Viridian Therapeutics saw its shares climb more than 10% to $19.81 in after-hours activity Friday, when it ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda (pembrolizumab), within ...

US biopharma Definium Therapeutics has closed an upsized public offering that raised $805 million in gross proceeds, days ...

CNX Therapeutics and Legacy Pharma have entered into a US commercial partnership for the launch of Ethyol (amifostine), with ...

German drugmaker Merck KGaA said today it will acquire US biotech firm Bio-Techne Corp for $11.3 billion, expanding its ...

Northern Ireland-based Galen has secured an expanded UK license for Penthrox (methoxyflurane), allowing the emergency pain ...

US biotech Ionis Pharmaceuticals yesterday announced that the US Food and Drug Administration (FDA) has approved Tryngolza ...

US genomic medicine company Sangamo Therapeutics has filed for Chapter 11 bankruptcy protection as it prepares to auction off ...

Candel Therapeutics (Nasdaq: CADL) has appointed oncology commercial veteran Mark Sims as chief commercial officer, effective ...

US clinical-stage biotech Ollin Biosciences has raised $330 million in an oversubscribed Series B round to fund global Phase ...

Japanese drugmaker Astellas Pharma has won European Commission (EC) approval for Padcev (enfortumab vedotin) in combination ...

UK biotech company RQ Bio has raised $115 million in a Series A round to advance RQB01, its lead long-acting antibody ...